Tyrosine phosphorylation profiling via in situ proximity ligation assay

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Elfineh, Lioudmila ^a   Classon, Christina ^a   Asplund, Anna ^a   Pettersson, Ulf ^a   Kamali Moghaddam, Masood ^a   Lind, Sara B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cancer biomarkers; in situ proximity ligation assay (in situ PLA); Protein signaling; Protein tyrosine phosphorylation

Indexed keywords

ABELSON KINASE; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SHC; TYROSINE;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; IMMUNOASSAY; IN SITU PROXIMITY LIGATION ASSAY; IN VITRO STUDY; LEUKEMIA CELL LINE; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; K562 CELL LINE; METABOLISM; PHOSPHORYLATION; PROCEDURES; PROTEIN PROCESSING;

HUMANS; IMMUNOHISTOCHEMISTRY; K562 CELLS; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TYROSINE;

EID: 84902057679     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-435     Document Type: Article

References (17)

1. Zwick E, Bange J, Ullrich A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 2001, 8(3):161-173.
2. Kolibaba KS, Druker BJ. Protein tyrosine kinases and cancer. Biochim Biophys Acta 1997, 1333(3):F217-F248.
3. Levitzki A. Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacol Ther 1999, 82(2-3):231-239.
4. Kanshin E, Michnick S, Thibault P. Sample preparation and analytical strategies for large-scale phosphoproteomics experiments. Semin Cell Dev Biol 2012, 23(8):843-853.
5. Bergstrom Lind S, Artemenko KA, Pettersson U. A strategy for identification of protein tyrosine phosphorylation. Methods 2012, 56:275-283.
6. Dunn JD, Reid GE, Bruening ML. Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry. Mass Spectrom Rev 2010, 29(1):29-54.
7. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J, Wester K, Hydbring P, Bahram F, Larsson LG, Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006, 3(12):995-1000.
8. Conze T, Carvalho AS, Landegren U, Almeida R, Reis CA, David L, Soderberg O. MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. Glycobiology 2010, 20(2):199-206.
9. Pinto R, Carvalho AS, Conze T, Magalhaes A, Picco G, Burchell JM, Taylor-Papadimitriou J, Reis CA, Almeida R, Mandel U, Clausen H, Soderberg O, David L. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. J Cell Mol Med 2012, 16(7):1474-1484.
10. Gu GJ, Lund H, Wu D, Blokzijl A, Classon C, von Euler G, Landegren U, Sunnemark D, Kamali-Moghaddam M. Role of Individual MARK Isoforms in Phosphorylation of Tau at Ser(262) in Alzheimer's Disease. Neuromolecular Med 2013, 15(3):458-469.
11. Jarvius M, Paulsson J, Weibrecht I, Leuchowius KJ, Andersson AC, Wahlby C, Gullberg M, Botling J, Sjoblom T, Markova B, Ostman A, Landegren U, Soderberg O. In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. Mol Cell Proteomics 2007, 6(9):1500-1509.
12. Landegren U, Vanelid J, Hammond M, Nong RY, Wu D, Ulleras E, Kamali-Moghaddam M. Opportunities for sensitive plasma proteome analysis. Anal Chem 2012, 84(4):1824-1830.
13. Andersson AC, Stromberg S, Backvall H, Kampf C, Uhlen M, Wester K, Ponten F. Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics. J Histochem Cytochem 2006, 54(12):1413-1423.
14. Bergstrom Lind S, Artemenko KA, Elfineh L, Mayrhofer C, Zubarev RA, Bergquist J, Pettersson U. Toward a comprehensive characterization of the phosphotyrosine proteome. Cell Signal 2011, 23(8):1387-1395.
15. Artemenko KA, Bergström Lind S, Elfineh L, Mayrhofer C, Zubarev RA, Bergquist J, Pettersson U. Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry. Analyst 2011, 136(9):1971-1978.
16. Bergstrom Lind S, Hagner-McWhirter S, Elfineh L, Molin M, Jorsback A, Ohman J, Pettersson U. Detection of tyrosine phosphorylated proteins by combination of immunoaffinity enrichment, two-dimensional difference gel electrophoresis and fluorescent Western blotting. Biochem Biophys Res Commun 2010, 401(4):581-585.
17. Goss VL, Lee KA, Moritz A, Nardone J, Spek EJ, MacNeill J, Rush J, Comb MJ, Polakiewicz RD. A common phosphotyrosine signature for the Bcr-Abl kinase. Blood 2006, 107(12):4888-4897.